Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Clover Health Investments ( (CLOV) ).
On October 9, 2025, Clover Health Investments announced the Centers for Medicare & Medicaid Services’ 2026 Star Ratings for its Medicare Advantage plans, with its PPO plans receiving 3.5 Stars and its HMO plan receiving 4.0 Stars. Despite these ratings, Clover Health is confident in its ability to drive above-market membership growth and increasing profitability through its technology-centric care strategy and AI-driven improvements in its Clover Assistant platform. The company emphasizes that its business model can sustain growth and profitability independent of the Star ratings, as demonstrated by its strong revenue and membership growth in the first half of 2025. Clover Health also highlights its high clinical quality scores and ongoing engagement with CMS to ensure its ratings reflect its health outcomes.
The most recent analyst rating on (CLOV) stock is a Buy with a $4.10 price target. To see the full list of analyst forecasts on Clover Health Investments stock, see the CLOV Stock Forecast page.
Spark’s Take on CLOV Stock
According to Spark, TipRanks’ AI Analyst, CLOV is a Neutral.
Clover Health’s stock score is influenced by its ongoing financial challenges, despite positive developments in operational metrics and an encouraging earnings call. The financial performance remains a significant concern due to negative margins and revenue decline. Technical indicators signal potential weakness, while valuation remains unattractive due to losses. The company’s achievements in profitability and membership growth offer potential for future improvement.
To see Spark’s full report on CLOV stock, click here.
More about Clover Health Investments
Clover Health (Nasdaq: CLOV) is a physician enablement technology company focused on providing access to high-quality healthcare for Medicare beneficiaries, particularly seniors who have historically faced challenges in accessing affordable care. The company offers PPO and HMO Medicare Advantage plans and leverages its Clover Assistant software platform to enhance clinical decision-making and health outcomes.
Average Trading Volume: 8,335,173
Technical Sentiment Signal: Sell
Current Market Cap: $1.38B
For a thorough assessment of CLOV stock, go to TipRanks’ Stock Analysis page.